Drug recall D-0213-2025

Class II Ongoing reported Feb 5, 2025

Product

Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01

Reason for recall

cGMP Deviations: Product intended for quarantine was inadvertently distributed.

Lots and codes

Lot# 04647349, Exp Date 5/31/2029

Recall details

Recalling firm
McKesson, Irving, TX
Quantity
192 vials
Distribution
Nationwide USA
Type
Voluntary: Firm initiated
Recall initiated
January 17, 2025

Related products